Company intelligence / Profile preview

Tong Xing Nuclear Technology

Beijing, China

Ownership: Private
Development stage: Other

Overview

Tong Xing is a commercial-stage company focused on producing and supplying Cobalt-60 for medical and industrial applications. The company has successfully supplied Cobalt-60 produced in CANDU reactors in China to international markets and is recognized as the world's third largest supplier of Cobalt-60[3][11].

Therapeutic areas: OncologyInfectious DiseasesOther
Modalities: RadiopharmaceuticalMedical isotope
Industry: Chemicals & Materials

Partnerships

Nordion (Canada) Inc. - Cobalt-60 supply agreement established in 2016 and expanded in 2019[3]Rosatom (Russia) - Collaboration on radiopharmaceuticals and nuclear medicine equipment development[12]

Beyond the preview

Go deeper on Tong Xing Nuclear Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tong Xing Nuclear Technology.

Explore the full profile